DEXWireNews

Salesforce Sees Annual Revenue Below Estimates

Long
BATS:CRM   Salesforce
Salesforce ( CRM ) expanded its stock buyback program by $10 billion and announced a new dividend, but its annual revenue forecast that was below estimates pushed its shares down around 2% in after hours trading.

The company's downbeat forecast signals a likely slowdown in cloud and tech spending as clients struggle with high interest rates and rising inflation, making them to keep a lid on costs.

The company sees revenue between $37.7 billion to $38 billion for full-year 2025, compared with analysts' estimate of $38.62 billion.

Warnings of a slow economy prompted Salesforce ( CRM ) to cut about 700 employees, or roughly 1% of its global workforce, last month, adding to the slew of layoffs across the tech and media industry.

"Salesforce is guiding for only 8-9% growth (for the full year), which moves it out of the high growth category. In order to make up for that, it is introducing a dividend, which is appropriate for the lower level of growth," said Gil Luria, analyst at D.A. Davidson.

However, Salesforce ( CRM ) beat revenue estimates for fourth-quarter revenue and profit as it benefited from higher cloud spending, joining other cloud giants like Amazon.com and Microsoft.

The company reported revenue of $9.29 billion for the quarter ended Jan. 31, beating analysts' estimate of $9.22 billion.

On an adjusted basis, the company earned $2.29 per share compared with estimates of $2.26 per share.

In early 2023, Salesforce had become a target for activist investors to push for changes resulting in cost cuts, increased share buybacks and a dismantled mergers and acquisition committee.

Salesforce ( CRM ) expects adjusted profit between $9.68 to $9.76 per share for the full-year, compared with estimates of $9.57 per share.

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our App on Google Play! dexwirenews.com/APP

2) Text Message Notifications: dexwirenews.com/SMS

3) Telegram: t.me/DEXWireNews

4) Follow Us on our Social Networks
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.